Re-invigorating rather than re-inventing the wheel: augmenting the impact of salvage autologous stem cell transplantation for multiple myeloma in the era of novel agents

被引：2
|
作者：
Cook, G. [1 ]
机构：
[1] Univ Leeds, Dept Haematol, Transplant Immunol Grp, Sect Expt Haematol,Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England
来源：
BONE MARROW TRANSPLANTATION | 2015年 / 50卷 / 10期
关键词：
HIGH-DOSE MELPHALAN; BORTEZOMIB; DEXAMETHASONE; THERAPY; PHASE-2; RELAPSE; TRIAL;
D O I：
10.1038/bmt.2015.175
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：1269 / 1270
页数：2
相关论文
共 50 条
  • [31] Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma
    Sato, Shuku
    Tsunoda, Shun
    Kawahigashi, Teiko
    Kamata, Wataru
    Tamai, Yotaro
    ANNALS OF HEMATOLOGY, 2023, 102 (05) : 1185 - 1191
  • [32] Clinical significance of high-dose chemotherapy with autologous stem cell transplantation in the era of novel agents in patients older than 65 years with multiple myeloma
    Shuku Sato
    Shun Tsunoda
    Teiko Kawahigashi
    Wataru Kamata
    Yotaro Tamai
    Annals of Hematology, 2023, 102 : 1185 - 1191
  • [33] Role Of Double Stem Cell Transplantation For Newly Diagnosed Multiple Myeloma In The Era Of Novel Agents
    Hagiwara, Shotaro
    Hirai, Risen
    Nakamura, Miki
    Tanimura, Akira
    Takeshita, Masataka
    Miwa, Akiyoshi
    BLOOD, 2013, 122 (21)
  • [34] Impact of failed response to novel agent induction in autologous stem cell transplantation for multiple myeloma
    Sung-Eun Lee
    Jae-Ho Yoon
    Seung-Hwan Shin
    Byung-Sik Cho
    Ki-Seong Eom
    Yoo-Jin Kim
    Hee-Je Kim
    Seok Lee
    Seok-Goo Cho
    Dong-Wook Kim
    Jong-Wook Lee
    Woo-Sung Min
    Chong-Won Park
    Chang-Ki Min
    Annals of Hematology, 2014, 93 : 627 - 634
  • [35] Impact of failed response to novel agent induction in autologous stem cell transplantation for multiple myeloma
    Lee, Sung-Eun
    Yoon, Jae-Ho
    Shin, Seung-Hwan
    Cho, Byung-Sik
    Eom, Ki-Seong
    Kim, Yoo-Jin
    Kim, Hee-Je
    Lee, Seok
    Cho, Seok-Goo
    Kim, Dong-Wook
    Lee, Jong-Wook
    Min, Woo-Sung
    Park, Chong-Won
    Min, Chang-Ki
    ANNALS OF HEMATOLOGY, 2014, 93 (04) : 627 - 634
  • [36] Cytomegalovirus reactivation after autologous stem cell transplantation in multiple myeloma patients treated with novel agents
    Naithani, R.
    Tarai, B.
    TRANSPLANT INFECTIOUS DISEASE, 2015, 17 (06) : 931 - 932
  • [37] Early stem cell transplantation for newly diagnosed multiple myeloma in the era of novel agents: it is time to stop
    Miles, Brittany
    Mackey, James
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S154 - S154
  • [38] Racial and Socioeconomic Disparities in the Utilization of Autologous Stem Cell Transplant for Treatment of Multiple Myeloma in the Era of Novel Agents
    Vardell, Victoria A.
    Ermann, Daniel
    Gbadamosi-Akindele, Maryam
    Badejo, Funmi
    Silberstein, Peter T.
    Tantravahi, Srinivas K.
    BLOOD, 2019, 134
  • [39] A New Prognostic Scoring System for Multiple Myeloma in the Era of Novel Agents and Autologous Stem Cell Transplantation: A Multicenter Retrospective Collaborative Study of the Japanese Society of Myeloma
    Ozaki, Shuji
    Saitoh, Takayuki
    Handa, Hiroshi
    Suzuki, Kenshi
    Takezako, Naoki
    Sunami, Kazutaka
    Kuroda, Yoshiaki
    Itagaki, Mitsuhiro
    Asaoku, Hideki
    Nagura, Eiichi
    Kazuyuki, Shimizu
    Murakami, Hirokazu
    BLOOD, 2016, 128 (22)
  • [40] Results of Salvage Autologous Stem Cell Transplantation (ASCT) for Relapsed Multiple Myeloma (MM) in the Era of Novel Agents: Outcome of Patients (Pts) Receiving Prior Bortezomib (BTZ)- Based Therapy
    Zarabi, Sara Farshchi
    Masih-Khan, Esther
    Chen, Christine
    Kukreti, Vishal
    Prica, Anca
    Tiedemann, Rodger
    Trudel, Suzanne
    Reece, Donna
    BLOOD, 2016, 128 (22)
12345